Joe Turner

Joe Turner has held various roles in finance and venture capital. Joe is currently the Chief Financial Officer at the Long-Term Stock Exchange and also serves as a Fractional CFO & Chief Business Officer at Karma Biotechnologies. In addition, Joe is a Network Partner at 2048 Ventures, where they focus on biotech investments. Joe has also worked as a Fractional, Interim CFO at Meru Health, a mental healthcare platform. Prior to their venture capital roles, Joe worked as a Managing Director at PJT Partners and as an Associate at Blackstone. Joe began their career as an Analyst at both Citi and HSBC. Overall, Joe has a strong background in finance and extensive experience in the venture capital industry.

Joe Turner's education history includes a Bachelor of Science (BSc) degree in Economics from the University of Bath, obtained between 2007 and 2011. Joe also attended Godalming College from 2004 to 2006, where they completed A (AS) Level courses in Mathematics, Economics, English Literature, and Psychology. In 2019 and 2020, they pursued Master of Science (MS) degrees in Global Finance from both NYU Stern School of Business and The Hong Kong University of Science and Technology. Additionally, Joe Turner obtained a verified certificate for "The Chemistry of Life" from edX in 2021.